MeiraGTx Holdings PLC (MGTX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$8.75

Buy

$9.50

arrow-up$0.20 (+2.29%)

Prices updated at 12 Dec 2025, 22:48 EST

Prices minimum 15 mins delay

Prices in USD

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Dr. Keith R. Harris, PhD

CEO

Dr. Alexandria Forbes, PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

409

Head office

450 East 29th Street

New York

United States

10016

+1 646 860-7985

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. Thomas E. Shenk, PhD Independent Director	0.09m
Ms. Nicole Seligman Independent Director	0.10m
Dr. Stuart Naylor, PhD Chief Development Officer	0.50m
Dr. Alexandria Forbes, PhD President, Chief Executive Officer and Director	0.84m
Dr. Robert K. Zeldin, M.D. Chief Medical Officer	-
Mr. Richard Giroux Chief Accounting Officer, Chief Operating Officer and Chief Financial Officer	0.71m
Dr. Keith R. Harris, PhD Chairman of the Board	0.16m
Dr. Ellen Hukkelhoven, PhD Director	-
Lord Neil Mendoza Independent Director	0.10m
Mr. Robert J. Wollin General Counsel and Secretary	-
Dr. Debra Yu, M.D. Independent Director	0.08m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Perceptive Advisors LLC	12,626,103
Sanofi	12,197,737
Johnson & Johnson	6,641,064
Adage Capital Management LP	5,229,099
Adage Capital Partners Gp LLC	4,184,578

Director dealings

Date chevron-l-regular chevron-r-regular	Action
06 Jun 2024	-
06 Jun 2024	-
06 Jun 2024	-
06 Jun 2024	-
06 Jun 2024	-
06 Jun 2024	-
05 Jun 2024	-
05 Jun 2024	-
05 Jun 2024	-
06 Jun 2024	-
05 Jun 2024	-
28 May 2024	-
05 Apr 2024	-
12 Mar 2024	-
29 Feb 2024	-
14 Jan 2024	-
17 Jan 2024	-
14 Jan 2024	-
14 Jan 2024	-
14 Jan 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.